154 related articles for article (PubMed ID: 28517961)
1. Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer.
Fesler A; Guo S; Liu H; Wu N; Ju J
Epigenomics; 2017 Jun; 9(6):793-796. PubMed ID: 28517961
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.
Liu X; Fu Q; Du Y; Yang Y; Cho WC
Curr Cancer Drug Targets; 2016; 16(9):738-754. PubMed ID: 26577538
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs are important regulators of drug resistance in colorectal cancer.
Zhang Y; Wang J
Biol Chem; 2017 Jul; 398(8):929-938. PubMed ID: 28095367
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1
Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G
Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and colorectal cancer chemoresistance: New solution for old problem.
Vaghari-Tabari M; Majidinia M; Moein S; Qujeq D; Asemi Z; Alemi F; Mohamadzadeh R; Targhazeh N; Safa A; Yousefi B
Life Sci; 2020 Oct; 259():118255. PubMed ID: 32818543
[TBL] [Abstract][Full Text] [Related]
8. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-141 inhibits tumor growth and minimizes therapy resistance in colorectal cancer.
Ye J; Wang Z; Zhao J; Chen W; Wu D; Wu P; Huang J
Mol Med Rep; 2017 Mar; 15(3):1037-1042. PubMed ID: 28112364
[TBL] [Abstract][Full Text] [Related]
11. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
13. Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.
Sun J; Xu K; Qiu Y; Gao H; Xu J; Tang Q; Yin P
Oncol Rep; 2017 Sep; 38(3):1420-1430. PubMed ID: 28731184
[TBL] [Abstract][Full Text] [Related]
14. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.
Zhang R; Xu J; Zhao J; Bai J
Oncotarget; 2017 Jul; 8(28):45213-45223. PubMed ID: 28423356
[TBL] [Abstract][Full Text] [Related]
16. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.
Pouya FD; Gazouli M; Rasmi Y; Lampropoulou DI; Nemati M
Mol Biol Rep; 2022 Jun; 49(6):5165-5178. PubMed ID: 35212928
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
19. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer defeating? Challenge accepted!
Di Franco S; Todaro M; Dieli F; Stassi G
Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
